  See all
 |
Articles: Neuro/Psych pharmacology |
Prior Articles
Use of Antidepressants for Management of Hot Flashes
Pharmacotherapy, 10/27/09
Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme
Cancer Chemotherapy and Pharmacology, 10/27/09 Ibuprofen for neuroprotection after cerebral ischemia
The Journal of Thoracic and Cardiovascular Surgery, 10/27/09 HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system
Current Medical Research and Opinion, 10/27/09
Exclusive Author Commentary Long-term treatment of patients with Alzheimers disease in primary and secondary care: results from an international survey
Current Medical Research and Opinion, 10/27/09 Baroreflex: A New Therapeutic Target in Human Stroke
Stroke, 10/26/09 Cerebrolysin: A Review of its Use in Dementia
Drugs & Aging, 10/26/09 Review: differences in efficacy and acceptability exist for 12 new-generation antidepressants for major depression
Evidence-Based Medicine, 10/26/09
Evidence Based Medicine
Revew Article
Potential neuroprotection mechanisms in PD: focus on dopamine agonist pramipexole
Current Medical Research and Opinion, 10/26/09 Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine2A Inverse Agonist for the Treatment of Insomnia
Journal of Pharmacology and Experimental Therapeutics, 10/26/09 Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes
Journal of Pharmacology and Experimental Therapeutics, 10/26/09 Exelixis and Bristol-Myers Squibb Report New Phase 2 Data for XL184 in Patients With the Most Common and Aggressive Form of Brain Cancer
Bristol Myers-Squibb Company, 10/26/09
Free full text
Health State Values during the First Year of Drug Treatment in Early-Stage Parkinson's Disease: A Prospective, Population-Based, Cohort Study
Drugs & Aging, 10/26/09 SR 57746A/xaliproden, a non-peptide neurotrophic compound: prospects and constraints for the treatment of nervous system diseases
Expert Opinion on Investigational Drugs, 10/26/09 Steroids for migraine headaches: a randomized double-blind, two-armed, placebo-controlled trial
The Journal of Emergency Medicine, 10/23/09 Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Drug and Alcohol Dependence, 10/23/09 Psychosis From Anticholinergic Medications Administered at a Smoking Cessation Clinic
Journal of Pharmacy Practice, 10/23/09 Recent Advances in Targeted Anti-Vasculature Therapy: The Neuroblastoma Model
Current Drug Targets, 10/23/09 Cannabinoids for Tourette's Syndrome
Cochrane Reviews, 10/22/09 Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: the SPHERE Study
Expert Review of Neurotherapeutics, 10/22/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
